Corcept Therapeutics (CORT) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Corcept Therapeutics (CORT) Company Statistics | The Fly

Corcept Therapeutics

· CORT

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

12.403 B

+0.43%

General

Market Cap: $12.4B
Enterprise Value: $12.35B
Shares Outstanding: 108,100,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 98.30%
Operating Margin: 0.77%
Net Profit Margin: 6.61%
FCF Margin: 12.87%
ROA: 6.18%
ROE: 8.37%
ROIC: 0.87%
Current Ratio: 2.86
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: 221.20
PEG: —
P/S: 14.99
P/FCF: 116.50
P/B: 17.65
EV/EBITDA: 429.14

Growth

Rev 1Y: 12.79%

Income Statement (TTM)

Revenue: $830.81M
Gross Margin: 98.30%
Operating Expenses: $810.32M
Operating Income: $6.41M
Net Profit: $54.9M

Balance Sheet

Rev 1Y Fwd Est

45.98%

Rev 3Y (CAGR)

23.74%

Rev 5Y (CAGR)

16.56%

Rev 10Y (CAGR)

31.23%

EPS 1Y

-33.33%

EPS 1Y Fwd Est

151.26%

EPS 3Y (CAGR)

-1.95%

EPS 5Y (CAGR)

-0.72%

EPS 10Y (CAGR)

—

Cash and Equivalents: $111.04M
Working Capital: $285.87M
Total Assets: $888.7M
Net Debt: -$101.62M
Total Liabilities: $182.93M
Total Equity: $705.78M

Cash Flow Statement (TTM)

Cash Flow from Operations: $109.7M
Cash Flow from Investing: -$21.9M
Cash Flow from Financing: -$78.91M
Free Cash Flow: $106.92M
Capital Expenditures: $2.78M